Works matching AU Baba, Masaru


Results: 31
    1

    Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real‐world setting.

    Published in:
    JGH Open, 2020, v. 4, n. 1, p. 54, doi. 10.1002/jgh3.12209
    By:
    • Sho, Takuya;
    • Suda, Goki;
    • Ogawa, Koji;
    • Kimura, Megumi;
    • Shimazaki, Tomoe;
    • Maehara, Osamu;
    • Shigesawa, Taku;
    • Suzuki, Kazuharu;
    • Nakamura, Akihisa;
    • Ohara, Masatsugu;
    • Umemura, Machiko;
    • Kawagishi, Naoki;
    • Natsuizaka, Mitsuteru;
    • Nakai, Masato;
    • Morikawa, Kenichi;
    • Furuya, Ken;
    • Baba, Masaru;
    • Yamamoto, Yoshiya;
    • Kobayashi, Tomoe;
    • Meguro, Takashi
    Publication type:
    Article
    2
    3

    Helicobacter fennelliae Localization to Diffuse Areas of Human Intestine, Japan.

    Published in:
    Emerging Infectious Diseases, 2024, v. 30, n. 1, p. 129, doi. 10.3201/eid3001.231049
    By:
    • Sakoh, Takashi;
    • Miyajima, Emiko;
    • Endo, Yusuke;
    • Kono, Kei;
    • Sato, Junichiro;
    • Haraguchi, Mizuki;
    • Ogura, Sho;
    • Morishima, Masayo;
    • Ishida, Keiko;
    • Ochiai, Yorinari;
    • Hoteya, Shu;
    • Takazawa, Yutaka;
    • Baba, Masaru;
    • Araoka, Hideki
    Publication type:
    Article
    4

    Efficacy and Safety of Durvalumab/Tremelimumab in Unresectable Hepatocellular Carcinoma as Immune Checkpoint Inhibitor Rechallenge Following Atezolizumab/Bevacizumab Treatment.

    Published in:
    Targeted Oncology, 2024, v. 19, n. 5, p. 769, doi. 10.1007/s11523-024-01092-7
    By:
    • Sho, Takuya;
    • Suda, Goki;
    • Ohara, Masatsugu;
    • Kohya, Risako;
    • Sasaki, Takashi;
    • Yoshida, Sonoe;
    • Hosoda, Shunichi;
    • Ogawa, Koji;
    • Kitagataya, Takashi;
    • Maehara, Osamu;
    • Ohnishi, Shunsuke;
    • Kawagishi, Naoki;
    • Natsuizaka, Mitsuteru;
    • Nakai, Masato;
    • Baba, Masaru;
    • Yamamoto, Yoshiya;
    • Tsukuda, Yoko;
    • Meguro, Takashi;
    • Yamada, Ren;
    • Kobayashi, Tomoe
    Publication type:
    Article
    5
    6
    7

    Positivity of high‐sensitivity HBsAg test, not previous HBV infection, indicates poor prognosis in patients with non‐HBV‐related HCC.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 10, p. 1315, doi. 10.1111/apt.18229
    By:
    • Yasuura, Naohiro;
    • Suda, Goki;
    • Ohara, Masatsugu;
    • Meno, Akimitsu;
    • Sho, Takuya;
    • Kohya, Risako;
    • Sasaki, Takashi;
    • Yoda, Tomoka;
    • Yoshida, Sonoe;
    • Fu, Qingjie;
    • Yang, Zijian;
    • Hosoda, Shunichi;
    • Maehara, Osamu;
    • Ohnishi, Shunsuke;
    • Saitou, Tomoya;
    • Sugiyama, Masaya;
    • Fukuhara, Takasuke;
    • Baba, Masaru;
    • Kitagataya, Takashi;
    • Kawagishi, Naoki
    Publication type:
    Article
    8

    Association of proteinuria with improved prognosis in unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab, and the predictive role of serum vascular endothelial growth factor D levels: A multicenter retrospective study.

    Published in:
    Hepatology Research, 2025, v. 55, n. 3, p. 433, doi. 10.1111/hepr.14139
    By:
    • Yang, Zijian;
    • Suda, Goki;
    • Sho, Takuya;
    • Maehara, Osamu;
    • Ohara, Masatsugu;
    • Yoda, Tomoka;
    • Fu, Qingjie;
    • Sasaki, Takashi;
    • Kohya, Risako;
    • Yoshida, Sonoe;
    • Hosoda, Shunichi;
    • Kitagataya, Takashi;
    • Kawagishi, Naoki;
    • Nakai, Masato;
    • Natsuizaka, Mitsuteru;
    • Ogawa, Koji;
    • Ohnishi, Shunsuke;
    • Yamamoto, Yoshiya;
    • Baba, Masaru;
    • Yamada, Ren
    Publication type:
    Article
    9

    Distribution of Fibrosis‐4 index and vibration‐controlled transient elastography‐derived liver stiffness measurement for patients with metabolic dysfunction‐associated steatotic liver disease in health check‐up.

    Published in:
    Hepatology Research, 2025, v. 55, n. 2, p. 191, doi. 10.1111/hepr.14117
    By:
    • Ogawa, Yuji;
    • Tomeno, Wataru;
    • Imamura, Yasushi;
    • Baba, Masaru;
    • Ueno, Takato;
    • Kobayashi, Takashi;
    • Iwaki, Michihiro;
    • Nogami, Asako;
    • Kessoku, Takaomi;
    • Honda, Yasushi;
    • Notsumata, Kazuo;
    • Fujikawa, Hirotoshi;
    • Kaai, Megumi;
    • Imajo, Kento;
    • Kawanaka, Miwa;
    • Hyogo, Hideyuki;
    • Hisatomi, Mitsurou;
    • Takeuchi, Mamiko;
    • Hakamada, Taku;
    • Honda, Takashi
    Publication type:
    Article
    10

    Early response and safety of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma in patients who do not meet IMbrave150 eligibility criteria.

    Published in:
    Hepatology Research, 2021, v. 51, n. 9, p. 979, doi. 10.1111/hepr.13693
    By:
    • Sho, Takuya;
    • Suda, Goki;
    • Ogawa, Koji;
    • Kimura, Megumi;
    • Kubo, Akinori;
    • Tokuchi, Yoshimasa;
    • Kitagataya, Takashi;
    • Maehara, Osamu;
    • Ohnishi, Shunsuke;
    • Shigesawa, Taku;
    • Nakamura, Akihisa;
    • Yamada, Ren;
    • Ohara, Masatsugu;
    • Kawagishi, Naoki;
    • Natsuizaka, Mitsuteru;
    • Nakai, Masato;
    • Morikawa, Kenichi;
    • Furuya, Ken;
    • Baba, Masaru;
    • Yamamoto, Yoshiya
    Publication type:
    Article
    11

    Lenvatinib in patients with unresectable hepatocellular carcinoma who do not meet the REFLECT trial eligibility criteria.

    Published in:
    Hepatology Research, 2020, v. 50, n. 8, p. 966, doi. 10.1111/hepr.13511
    By:
    • Sho, Takuya;
    • Suda, Goki;
    • Ogawa, Koji;
    • Shigesawa, Taku;
    • Suzuki, Kazuharu;
    • Nakamura, Akihisa;
    • Ohara, Masatsugu;
    • Umemura, Machiko;
    • Kawagishi, Naoki;
    • Natsuizaka, Mitsuteru;
    • Nakai, Masato;
    • Morikawa, Kenichi;
    • Furuya, Ken;
    • Baba, Masaru;
    • Ito, Jun;
    • Yamamoto, Yoshiya;
    • Kobayashi, Tomoe;
    • Meguro, Takashi;
    • Saga, Akiyoshi;
    • Miyagishima, Takuto
    Publication type:
    Article
    12

    Entecavir treatment of hepatitis B virus‐infected patients with severe renal impairment and those on hemodialysis.

    Published in:
    Hepatology Research, 2019, v. 49, n. 11, p. 1294, doi. 10.1111/hepr.13399
    By:
    • Suzuki, Kazuharu;
    • Suda, Goki;
    • Yamamoto, Yoshiya;
    • Furuya, Ken;
    • Baba, Masaru;
    • Kimura, Megumi;
    • Maehara, Osamu;
    • Shimazaki, Tomoe;
    • Yamamoto, Koji;
    • Shigesawa, Taku;
    • Nakamura, Akihisa;
    • Ohara, Masatsugu;
    • Kawagishi, Naoki;
    • Nakai, Masato;
    • Sho, Takuya;
    • Natsuizaka, Mitsuteru;
    • Morikawa, Kenichi;
    • Ogawa, Koji;
    • Sakamoto, Naoya
    Publication type:
    Article
    13

    Assessing the risk of hepatocellular carcinoma by combining liver stiffness and the controlled attenuation parameter.

    Published in:
    Hepatology Research, 2019, v. 49, n. 10, p. 1207, doi. 10.1111/hepr.13391
    By:
    • Izumi, Takaaki;
    • Sho, Takuya;
    • Morikawa, Kenichi;
    • Shigesawa, Taku;
    • Suzuki, Kazuharu;
    • Nakamura, Akihisa;
    • Ohara, Masatsugu;
    • Kawagishi, Naoki;
    • Umemura, Machiko;
    • Shimazaki, Tomoe;
    • Kimura, Megumi;
    • Nakai, Masato;
    • Suda, Goki;
    • Natsuizaka, Mitsuteru;
    • Ogawa, Koji;
    • Kudo, Yusuke;
    • Nishida, Mutsumi;
    • Ono, Kota;
    • Baba, Masaru;
    • Furuya, Ken
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20

    Efficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrave150.

    Published in:
    Cancers, 2022, v. 14, n. 16, p. 3938, doi. 10.3390/cancers14163938
    By:
    • Sho, Takuya;
    • Suda, Goki;
    • Yamamoto, Yoshiya;
    • Furuya, Ken;
    • Baba, Masaru;
    • Ogawa, Koji;
    • Kubo, Akinori;
    • Tokuchi, Yoshimasa;
    • Fu, Qingjie;
    • Yang, Zijian;
    • Kimura, Megumi;
    • Kitagataya, Takashi;
    • Maehara, Osamu;
    • Ohnishi, Shunsuke;
    • Nakamura, Akihisa;
    • Yamada, Ren;
    • Ohara, Masatsugu;
    • Kawagishi, Naoki;
    • Natsuizaka, Mitsuteru;
    • Nakai, Masato
    Publication type:
    Article
    21
    22

    Prophylactic tenofovir alafenamide for hepatitis B virus reactivation and reactivation‐related hepatitis.

    Published in:
    Journal of Medical Virology, 2023, v. 95, n. 2, p. 1, doi. 10.1002/jmv.28452
    By:
    • Suda, Goki;
    • Baba, Masaru;
    • Yamamoto, Yoshiya;
    • Sho, Takuya;
    • Ogawa, Koji;
    • Kimura, Megumi;
    • Hosoda, Shunichi;
    • Yoshida, Sonoe;
    • Kubo, Akinori;
    • Fu, Qingjie;
    • Yang, Zijian;
    • Tokuchi, Yoshimasa;
    • Kitagataya, Takashi;
    • Maehara, Osamu;
    • Ohnishi, Shunsuke;
    • Yamada, Ren;
    • Ohara, Masatsugu;
    • Kawagishi, Naoki;
    • Natsuizaka, Mitsuteru;
    • Nakai, Masato
    Publication type:
    Article
    23

    Serum Angiopoietin-2 Predicts the Occurrence and Recurrence of Hepatocellular Carcinoma after Direct-Acting Antiviral Therapy for Hepatitis C.

    Published in:
    Viruses (1999-4915), 2023, v. 15, n. 1, p. 181, doi. 10.3390/v15010181
    By:
    • Kawagishi, Naoki;
    • Suda, Goki;
    • Yamamoto, Yoshiya;
    • Baba, Masaru;
    • Furuya, Ken;
    • Maehara, Osamu;
    • Ohnishi, Shunsuke;
    • Yoshida, Sonoe;
    • Fu, Qingjie;
    • Yang, Zijian;
    • Hosoda, Shunichi;
    • Tokuchi, Yoshimasa;
    • Kitagataya, Takashi;
    • Ohara, Masatsugu;
    • Suzuki, Kazuharu;
    • Nakai, Masato;
    • Sho, Takuya;
    • Natsuizaka, Mitsuteru;
    • Ogawa, Koji;
    • Sakamoto, Naoya
    Publication type:
    Article
    24

    Tri-antennary tri-sialylated mono-fucosylated glycan of alpha-1 antitrypsin as a non-invasive biomarker for non-alcoholic steatohepatitis: a novel glycobiomarker for non-alcoholic steatohepatitis.

    Published in:
    Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-019-56947-1
    By:
    • Ogawa, Koji;
    • Kobayashi, Takashi;
    • Furukawa, Jun-ichi;
    • Hanamatsu, Hisatoshi;
    • Nakamura, Akihisa;
    • Suzuki, Kazuharu;
    • Kawagishi, Naoki;
    • Ohara, Masatsugu;
    • Umemura, Machiko;
    • Nakai, Masato;
    • Sho, Takuya;
    • Suda, Goki;
    • Morikawa, Kenichi;
    • Baba, Masaru;
    • Furuya, Ken;
    • Terashita, Katsumi;
    • Kobayashi, Tomoe;
    • Onodera, Manabu;
    • Horimoto, Takahiro;
    • Shinada, Keisuke
    Publication type:
    Article
    25
    26
    27

    Tenofovir–disoproxil–fumarate modulates lipid metabolism via hepatic CD36/PPAR-alpha activation in hepatitis B virus infection.

    Published in:
    Journal of Gastroenterology, 2021, v. 56, n. 2, p. 168, doi. 10.1007/s00535-020-01750-3
    By:
    • Suzuki, Kazuharu;
    • Suda, Goki;
    • Yamamoto, Yoshiya;
    • Furuya, Ken;
    • Baba, Masaru;
    • Nakamura, Akinobu;
    • Miyoshi, Hideaki;
    • Kimura, Megumi;
    • Maehara, Osamu;
    • Yamada, Ren;
    • Kitagataya, Takashi;
    • Yamamoto, Koji;
    • Shigesawa, Taku;
    • Nakamura, Akihisa;
    • Ohara, Masatsugu;
    • Kawagishi, Naoki;
    • Nakai, Masato;
    • Sho, Takuya;
    • Natsuizaka, Mitsuteru;
    • Morikawa, Kenichi
    Publication type:
    Article
    28
    29
    30
    31

    Baseline serum angiopoietin-2 and VEGF levels predict the deterioration of the liver functional reserve during lenvatinib treatment for hepatocellular carcinoma.

    Published in:
    PLoS ONE, 2021, v. 16, n. 3, p. 1, doi. 10.1371/journal.pone.0247728
    By:
    • Shigesawa, Taku;
    • Suda, Goki;
    • Kimura, Megumi;
    • Maehara, Osamu;
    • Tokuchi, Yoshimasa;
    • Kubo, Akinori;
    • Yamada, Ren;
    • Furuya, Ken;
    • Baba, Masaru;
    • Kitagataya, Takashi;
    • Suzuki, Kazuharu;
    • Ohara, Masatsugu;
    • Kawagishi, Naoki;
    • Nakai, Masato;
    • Sho, Takuya;
    • Natsuizaka, Mitsuteru;
    • Morikawa, Kenichi;
    • Ogawa, Koji;
    • Sakamoto, Naoya
    Publication type:
    Article